Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02914730 · ClinicalTrials.gov registry record

Insulin Dosing Practices in Persons With Diabetes on Multiple Daily Injections

A clinical trial of Diabetes and Medication Adherence, sponsored by Joslin Diabetes Center.

Completed
Registry status
75
Enrollment target
1
Study location

NCT02914730 is a study of Diabetes and Medication Adherence that has completed, run by Joslin Diabetes Center. The registered enrollment target is 75 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02914730, a study of Diabetes and Medication Adherence, has completed, sponsored by Joslin Diabetes Center.

COMPLETED
Registry status
75 participants
Enrollment target
1
Study location

Study Summary

In this cross-sectional study the investigators will examine two populations: young adults with (ages 18-35) and older adults (ages 65 and over) with diabetes who are on \> 2 insulin injections per day. The sample size for this observational study will be up to 125 patients. The investigators will issue a Common Sensing GoCap bluetooth-enabled pen cap that fits on the end of Solostar Lantus and Apidra insulin pens; this pen cap registers the position of the insulin pen plunger and automatically sends confirmation of dose delivery to a smartphone app.

Study Locations (1)

Massachusetts

  • Joslin DIabetes Center - Boston

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2016-09
Est. Completion 2018-07

Sponsor

Joslin Diabetes Center

73 total trials

What the Registry Record Tells You About NCT02914730

The ClinicalTrials.gov registry entry for NCT02914730 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (98% lower). The listed sponsor is Joslin Diabetes Center, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Diabetes appearing as the primary indexed condition, and to 0 interventions.

NCT02914730 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02914730 about?

NCT02914730 is a clinical study titled "Insulin Dosing Practices in Persons With Diabetes on Multiple Daily Injections". In this cross-sectional study the investigators will examine two populations: young adults with (ages 18-35) and older adults (ages 65 and over) with diabetes who are on \> 2 insulin injections per day. The sample size for this observational study will be up to 125 patients. The investigators will i...

What is the current status of trial NCT02914730?

This trial is currently completed. The enrollment target is 75 participants. The study started on 2016-09. Estimated completion is 2018-07.

What conditions does trial NCT02914730 study?

This clinical trial studies the following conditions: Diabetes, Medication Adherence, Insulin, Technology.

Who is sponsoring clinical trial NCT02914730?

This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02914730 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.